https://www.marketscreener.com/quote/stock/MITSUBISHI-TANABE-PHARMA--6492203/news/Mitsubishi-Tanabe-Pharma-America-Presents-48-Week-Results-from-Global-Phase-3-Safety-Clinical-Study-40619519/?utm_source=telegram&utm_medium=social&utm_campaign=share